ERBB2 and breast cancer: Using the same methods and criteria as in breast cancer a recent study of 1005 primary UC samples found HER2 overexpression in 9.2% of tumor samples and HER2 gene amplification rate by FISH in 5.1%, with a complete concordance between 3+ protein expression level and gene amplification [11].